GET DAILY SIGNALSClarivate (CLVT) Q3 2026: EPS Beat and Modest Organic Growth Amid Portfolio Shift
Key Takeaways
- Clarivate Plc reported third quarter 2026 revenue from continuing operations of $481.6 million, down 9.2% from $530.3 million a year earlier, primarily due to divestitures and product wind-downs.
- Adjusted diluted earnings per share (EPS) rose to $0.21, up from $0.18 in the prior-year period and ahead of consensus estimates of roughly $0.18.
- Organic revenue growth turned modestly positive at 0.4%, while organic annualized contract value (ACV) growth reached 1.8%, led by a return to growth in the Intellectual Property (IP) segment.
- Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) for continuing operations was $218.2 million, with the margin expanding to 45.3% on cost efficiencies.
- The company completed the sale of its Life Sciences & Healthcare (LS&H) segment on October 6, 2026 for $488.4 million in net proceeds, sharpening its focus on Academia & Government and IP.
- For deeper coverage of this ticker, explore Major News, Today's Price Move, Price Targets, and Forecast on additional pages.
- Discover automated trading ideas by exploring Trending AI Robots.
Why These Results Matter in the Broader Transformation
Clarivate's third quarter 2026 results mark a pivotal moment in the company's multi-year transformation. The early completion of the Life Sciences & Healthcare divestiture leaves a more focused, recurring-revenue-driven business centered on two scaled franchises, Academia & Government and Intellectual Property, with roughly 93% of revenue now recurring. Investors have been watching closely for evidence that the company's cost discipline and artificial intelligence (AI) initiatives can translate into durable organic growth. The report also matters because it resets full-year guidance to reflect the divested segment, giving the market a cleaner view of the go-forward earnings power and cash generation of the remaining operations. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Reported Results
Clarivate reported third quarter revenue from continuing operations of $481.6 million, down 9.2% from $530.3 million in the prior-year quarter. The decline was driven primarily by inorganic disposals, including the wind-down of the Academia & Government books business. Organic revenue growth was 0.4%, reflecting 1.5% organic subscription growth and 0.7% organic re-occurring growth, partially offset by lower transactional revenue.
Adjusted diluted EPS was $0.21, an increase of $0.03 versus the prior year and ahead of the consensus estimate of about $0.18. Adjusted EBITDA from continuing operations was $218.2 million, with the adjusted EBITDA margin widening to 45.3% from 41.9% a year earlier. On a GAAP (Generally Accepted Accounting Principles) basis, the company reported a net loss of $80.8 million, or $0.13 per diluted share, compared with a net loss of $28.3 million in the prior year, largely due to a $62.2 million non-cash goodwill impairment tied to the LS&H segment.
Organic ACV growth was 1.8%, a 30-basis-point improvement year over year. Free cash flow was $110.2 million for the quarter, while total debt declined by $293.8 million year to date. From what I see, the margin expansion stands out as a clear sign of operational progress.
Market Reaction and Investor Sentiment
Heading into the report, sentiment around CLVT remained cautious, with the stock trading well below its 200-day moving average after giving back much of its mid-year rally. Investors were focused on whether the company could deliver the recurring-growth inflection management had been signaling, while also bracing for lower full-year guidance following the divestiture. The initial market reaction was positive, with shares moving higher as the market rewarded the EPS beat, margin expansion, and the return to positive ACV growth in the IP segment. Still, the revenue shortfall and trimmed full-year organic growth and free cash flow targets tempered enthusiasm, underscoring that the recovery remains modest and heavily back-end loaded to the fourth quarter.
Forward Outlook and Key Factors to Monitor
Following the divestiture, Clarivate updated its full-year 2026 outlook to reflect continuing operations only. Management now expects revenue of $1.965 billion to $1.985 billion, adjusted EBITDA of $865 million to $885 million, adjusted diluted EPS of $0.73 to $0.77, and free cash flow of $320 million to $340 million. The company also guided to organic ACV growth of 1.75% to 2.25%.
The most important near-term test is the fourth quarter, where management expects recurring organic revenue growth to exceed 2%, which would mark the highest quarterly level in more than three years. Investors should watch whether ACV gains broaden beyond pricing into genuine volume growth, and whether transactional revenue headwinds continue to fade as low-margin products are wound down.
Beyond the quarter, key catalysts include the November early-adopter launch of IPOne, the company's AI-native intelligence layer, and continued customer adoption of Web of Science Research Intelligence. Management also offered an early 2027 view of higher organic ACV and recurring revenue growth, free cash flow growth of 10% to 15%, and further debt reduction. Balance sheet progress, the pace of leverage reduction, and foreign exchange impacts on profitability remain important factors to monitor through the remainder of the year.
Refining Research with AI Tools
I often rely on Tickeron’s AI Screener when evaluating companies like this one during periods of restructuring. The tool lets me quickly filter for patterns in fundamentals, technical signals, and peer performance, which helps put the quarter’s organic growth and margin trends into better context without spending hours on manual screens. It has become a regular part of my process for spotting comparable names and confirming where CLVT stands relative to the broader group.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Momentum Indicator for CLVT turns negative, indicating new downward trend
CLVT saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned negative. In 77 of the 84 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
CLVT moved below its 50-day moving average on October 27, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLVT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for CLVT entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CLVT's RSI Oscillator exited the oversold zone, 32 of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for CLVT just turned positive on October 13, 2026. Looking at past instances where CLVT's MACD turned positive, the stock continued to rise in 37 of 46 cases over the following month. The odds of a continued upward trend are 80%.
Following a +6.25% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLVT advanced for three days, in 161 of 245 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
CLVT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 26 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.234) is normal, around the industry mean (2.802). P/E Ratio (-3.192) is within average values for comparable stocks, (18.164). Projected Growth (PEG Ratio) (0.178) is also within normal values, averaging (2.284). Dividend Yield (0.000) settles around the average of (0.195) among similar stocks. P/S Ratio (0.504) is also within normal values, averaging (139.965).
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. CLVT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLVT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
What is a Life Estate?
What is the essence of Trickle-Down Economics, and how does it function in practice?
Asset Acquisition: Top Market Leaders
What Are the 6 Essential Books for Becoming a Successful Options Trader?
Why NVIDIA May Lose China Sales but Win the AI Battle: Short and Long Term Considerations
General Information
a maker of activated carbon and related products and systems
Industry InformationTechnologyServices
Advertisement